Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Therapeutic equivalence of generic formoterol 12 µg DPI vs Oxis 12 µg Turbuhaler in asthma
2006-000683-84Phase 3Completed
- Sponsor
- Andi-Ventis
- Start
- Feb 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of formoterol in asthma (2 arms), sponsored by Andi-Ventis. Primary endpoint: Mean morning PEFR before morning dose. Started Feb 2006; status: completed.
02
Drugs
formoterol
03
Conditions
asthma
Beyond the preview
Go deeper on 2006-000683-84.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000683-84.